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S U M M A R Y
The T cell branch of the immune system has been extensively studied in the elderly and it is known that
the elderly have impaired immune function, mainly due to the chronic antigenic load that ultimately
causes shrinkage of the T cell repertoire and ﬁlling of the immunologic space with memory T cells. In the
present paper, we describe the IgDCD27 double-negative B cell populationwhich (as we have recently
described) is higher in the elderly. Most of these cells were IgG+. Evaluation of the telomere length and
expression of the ABCB1 transporter and anti-apoptotic molecule, Bcl2, shows that they have the
markers of memory B cells. We also show that these cells do not act as antigen presenting cells, as
indicated by the low levels of CD80 and DR, nor do they express signiﬁcant levels of the CD40 molecule
necessary to interact with T lymphocytes through the ligand, CD154. Hence, we hypothesize that these
expanded cells are late memory or exhausted cells that have down-modulated the expression of CD27
and ﬁlled the immunologic space in the elderly. These cells might be the age-related manifestation of
time-enduring stimulation or dysregulation of the immune system.
 2009 Elsevier Ireland Ltd. All rights reserved.
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The immune system of the elderly has been extensively studied,
for the most part involving the T cell branch (Miller, 2000; Pawelec
et al., 2002a). As a result, we know that the elderly have decreased
immune function due mainly to the chronic antigenic load that
ultimately causes shrinkage of the T cell repertoire and ﬁlling of the
immunologic space with memory T cells (Franceschi et al., 2000;
Pawelec et al., 2005). The direct consequence of these changes,
together with the reduced output of naı¨ve cells from the thymus
(Pawelec et al., 2002a), is a reduction of antigen-inexperienced T
lymphocytes available for adequate immune response against
newly encountered antigens, in particular, infectious agents
(Pawelec et al., 2002b, 2004, 2005).
In contrast to T cells, B lymphocytes have not been extensively
studied in the elderly (Weksler, 2000; Weksler and Szabo, 2000;
Colonna-Romano et al., 2003), although the B cell branch is
involved in some hematological cancers common in the elderly,
such as chronic lymphatic leukemia (Chiorazzi et al., 2005), and in
the increased autoimmune responses observed in the elderly
(Candore et al., 1997). On the other hand, although B cells are* Corresponding author. Tel.: +39 0916555906; fax: +39 0916555933.
E-mail address: gcolonna@unipa.it (G. Colonna-Romano).
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Colonna-Romano et al., 2002), total serum immunoglobulin levels
do not actually change (Le Maoult et al., 1997; Weksler and Szabo,
2000). However, we have recently reported a reduced ability of the
elderly to produce IgD that is expressed together with IgM on
mature B cells newly produced by the bone marrow, as
demonstrated by low serum levels of this isotype (Listı` et al.,
2006). Interestingly, we have also shown an age-related increase in
IgG and IgA levels, whereas there is an age-related decrease in IgM
levels (Listı` et al., 2006). We and others (Colonna-Romano et al.,
2003; Gupta et al., 2005) have also shown that in the elderly there
is a signiﬁcant decrease in naı¨ve CD27 B lymphocytes and no
signiﬁcant reciprocal increase in CD27+memory B cells (Klein et al.,
1998; Agematsu et al., 2000). On the other hand, Shi et al. (2005)
have shown that CD27+ memory B cells, particularly
IgD+IgM+CD27+ IgM memory B cells, decline dramatically in
elderly subjects.
Different subsets of memory CD27+ B cells and CD27 naı¨ve B
cells have been described (Shi et al., 2003; Fecteau et al., 2006;Wei
et al., 2007), providing the immunity and ageing ﬁelds with new
opportunities to gain insight into B cell immunosenescence.
Accordingly, we have recently focused our attention on B cell
subpopulations, demonstrating that a double-negative (DN)
IgDCD27 B cell subset is signiﬁcantly higher in the elderly
(Colonna-Romano et al., 2008). In the present report, we describe
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and old donors. We suggest that these cells, which are expanded in
the elderly, might be the age-related manifestation of a time-
enduring stimulation or dysregulation of the immune system.
2. Materials and methods
2.1. Subjects
Eighty-eight healthy Sicilian subjects were studied (thirty-nine young, age range
20–55 years, mean 37.5  17.5, median 35 years) and forty-nine elderly (age range
75–102 years, mean 89.0  13, median 91 years). None of the selected subjects had
neoplastic, infectious, autoimmune diseases, or received any medications inﬂuencing
immune function at the time of the study. All subjects gave informed consent according
to Italian law.
2.2. Cell preparation, activation, B lymphocyte separation, and ﬂow cytometry analysis
Peripheral blood mononuclear cells (PBMCs) were isolated from heparinized
venous blood by density gradient centrifugation on Ficoll-Lympholyte (Cedarlane
Laboratories Limited, Ontario, Canada). PBMCswere adjusted to 1  106/ml in RPMI
1640 medium (Euroclone, Devon, UK) supplemented with 10% heat-inactivated
fetal calf serum (Euroclone), 1% penicillin/streptomicin, 10 mMHEPES, and 1 mML-
glutamine.
In some experiments PBMCs have been activated with unmethylated single-
stranded DNA motif (CpG oligonucleotides), or with anti-BCR [F(ab0)2] (Jackson
ImmunoResearch Laboratories, Inc, Philadelphia) as follows: PBMCs were isolated
from heparinized venous blood by density gradient centrifugation on Ficoll-
Lympholyte (Cedarlane Laboratories Limited, Ontario, Canada), then were adjusted
to 1  106/ml in RPMI 1640 medium (Euroclone, Devon, UK) supplemented with
10% heat-inactivated fetal calf serum (Euroclone), 1% penicillin/streptomicin,
10 mM HEPES, and 1 mM L-glutamine. Cells were then cultured in 24-well plate
bottom in medium or were activated with 10 mg/ml of CpG oligodeoxynucleotide
(TIB Molbiol, Genova, Italy), or with 2mg/ml of F (ab0)2), for 5 days. Then Ki67
expression was evaluated (see below).
B lymphocytes were separated from PBMCs by immunomagnetic sorting, as
described by Miltenyi et al. (1990) using anti-CD19 magnetic microbeads (MACS
CD19 Multisort Microbeads; Miltenyi Biotec, Aubum, CA, USA). The cells obtained
from immunomagnetic sorting were >98% CD19+ lymphocytes, as determined by
ﬂow cytometry analysis.
Total PBMCs or puriﬁed B cells were stained with different combinations of the
following monoclonal antibodies: anti-IgDFITC, anti-IgGFITC, anti-CD40PE, anti-HLA-
DRPE, anti-CD19PE, anti-IgDPE, and anti-CD27APC (Pharmingen, BD Bioscience,
Mountain View, CA, USA), anti-CD80TC
TM (Caltag, Burlingame, CA, USA).
For Ki67 evaluation (Lopez et al., 1991), activated PBMCs were ﬁrst stained with
anti-IgDPE or anti IgGPE, anti-CD19PECy5, anti-CD27APC. Then the cells were ﬁxed
with 100ml of Perm& Fix Solution A (Caltag Burlingame) for 20 min at 4 8C, washed
twice with PBS-BSA (0.2%) and permeabilized with 500 ml of Perm & Fix Solution B
(Caltag Burlingame) for 10 min at RT. Then cells were stained for 40 min on ice with
20 ml of anti-Ki67FITC (Pharmingen). After two washings the Ki67 positive cells
were analyzed.
All measurements were made with a FACSCalibur ﬂow cytometer (Becton
Dickinson, San Jose, CA, USA) with the same instrument setting. At least 104 cells
were analyzed using CellQuestPro (Becton Dickinson, San Jose, CA, USA) software.
2.3. Bromodeoxyuridine (BrdU) incorporation
To evaluate bromodeoxyuridine (BrdU) incorporation, separated PBMCs were
cultured in 24-well plate bottom in medium with 10mM of BrdU (kit BD-
Bioscience) and then they were activated with 10 mg/ml of CpG oligodeoxynucleo-
tide (TIBMolbiol, Genova, Italy) or 2mg/ml of F (ab0)2 (Jackson Immunoresearch) for
5 days. Activated PBMC were ﬁrst stained with anti-CD27FITC, anti-IgDPE, anti-
CD19PECy5. Then the cells were ﬁxed with 100ml of Perm & Fix Solution A (Caltag
Burlingame) for 20 min at 4 8C, washed twice with PBS-BSA (0.2%) and
permeabilized with 500ml of Perm & Fix Solution B (Caltag Burlingame) for
20 min at RT, washed twice and incubated with 300mg/ml of DNase (kit BD-
Bioscience) for 60 min at 37 8C. Then cells were re-suspended in 50ml of PBS and
stained with 1ml of anti-BrdUAPC (kit BD-Bioscience) for 20 min at RT, washed and
analyzed.
2.4. Evaluation of the ATP-binding cassette-B1 transporter (ABCB1)
To evaluate the ABCB1 transporter, CD19+ cells were incubated with 25mM of
cyclosporin A, which allows the exposure of the epitope of the active conformation
of the ABCB1 protein (Wirths and Lanzavecchia, 2005), and 20ml of anti-ABCB1PE
(clone UIC2 MsIgG2a; Coulter Immunotech, Marseille Cedex, France), for 1 h at
37 8C in awater bath. Then the cells were incubated for 20 min at room temperature
with anti-CD27APC and anti-IgDFITC. The ﬂuorescence was then measured with a
FACSCalibur ﬂow cytometer. The results are expressed as the mean ﬂuorescence
intensity (MFI) mean  SE.2.5. Evaluation of telomere length
Telomere length was evaluated by the ﬂow-ﬁsh technique, as described by Rufer
et al. (1998). Magnetically sorted CD19+ B cells were labelled with antibodies
speciﬁc for the surfacemarkers (i.e. anti-IgDFITC and anti-CD27APC) andwashedwith
phosphate buffered saline (PBS) with 0.2%weight/volume of bovine serum albumin
(BSA; Sigma Chemical Co, St. Louis, MO, USA Then the cells were ﬁxed and
permeabilizated with Fix and Perm (Caltag, Burlingame, CA, USA), according to the
manufacturer’s instructions. Brieﬂy, cells were ﬁrst incubated with 100 ml of
solution A for 15 min in the dark at room temperature, washed with PBS 0.2% BSA,
then incubated for 15 min with solution B under the same conditions, and washed
twice with PBS-BSA (0.2%). PBMCs were then washed twice with hybridization
solution containing 70% de-ionized formamide, 20 mM Tris (pH 7.1), 1% BSA, and
15 mMNaCl (Sigma Chemical). The cell pellet was gently re-suspendedwith 200ml
of hybridization solution and incubated with 0.3 mg/ml of (C3TA2)3 PNA probe Cy5-
conjugated (Applied Biosystems, Bedford, MA, USA). The cell suspension was
maintained at room temperature for 10 min prior to denaturation in a circulating
water bath at 87 8C for 15 min. Hybridization was performed for 90 min at room
temperature in the dark. Four washes were performed at room temperature by
adding 1 ml of 70% de-ionized formamide, 10 mM Tris (pH 7.1), 0.1% BSA, and 0.1%
Tween 20 (Sigma Chemical), followed by centrifugation of the tubes at 1500  g for
5 min at 16 8C and aspiration of the supernatant, leaving 100ml in which the cell
pellet was gently re-suspended before addition andmixing with 1 ml of fresh wash
ﬂuid. The last wash step was performed with 1 ml of 5% glucose, containing 10 mM
Hepes, 0.1% BSA, and 0.1% Tween 20 (Sigma Chemical), and centrifugation was at
900 g for 5 min at 16 8C. The cell pellet was shaken and the cells were
counterstained with FACSFlow (Becton Dickinson) containing 0.1% BSA.
The ﬂuorescence was then measured with a FACSCalibur ﬂow cytometer. The
results are expressed as the MFI mean  SE of the PNA probe incorporation.
2.6. Intracellular staining of Bcl2
CD19+ lymphocyteswere ﬁrstly stainedwith anti-IgDFITC and anti-CD27APC. Then
the cells were permeabilizated with 150ml of permeabilization buffer (Pharmin-
gen, BD Bioscience, Mountain View, CA, USA) for 20 min at room temperature,
washed twice with PBS-BSA (0.2%) and stained for 30 min at room temperature
with 20ml of anti-Bcl2PE (Pharmingen). After two washings, the Bcl2-positive cells
were analyzed. The results are expressed as the MFI mean  SE.
2.7. Statistical analysis
Values (percentage or MFI), given as the mean  SD or SE, were compared using
one-way analysis of variance (ANOVA). Differences were considered signiﬁcant when a
p value <0.05 was obtained by comparison between the different groups.
3. Results
3.1. Analyses of CD19+ cell subpopulations on the basis of IgD and
CD27 expression
We analyzed circulating CD19+ lymphocytes obtained from the
peripheral blood of young and elderly subjects. The analyses were
performed after staining B cells identiﬁed by anti-CD19 antibody
or sorted by immunomagnetic beads with a combination of anti-
IgD and anti-CD27 ﬂuorochrome-conjugated antibodies. In both
cases, the results were similar (data not shown). As shown in Fig. 1,
we identiﬁed IgD+CD27, IgD+CD27+, IgDCD27+, and IgDCD27
(i.e. DN) B cells. Remarkably, in the elderly we observed a
signiﬁcant reduction of IgD+CD27 naı¨ve B cells (young, 49.5  2.9;
elderly, 40.1  3.9; p = 0.005) and a highly signiﬁcant increase of
IgDCD27 (DN) B cells (young, 5.8  0.5; elderly, 14.9  2.1;
p = 0.0001). No differences in the percentage of the other two
subpopulations of B cells were found.
3.2. Immunoglobulin expression of DN B cells
We evaluated the expression of membrane immunoglobulin on
DN B cells. Initial presumptive evidence suggested to us that these
cells were IgG-positive. In fact, the percentages of DN cells and
IgG+CD27 were nearly the same in the subjects studied (data not
shown). Further analysis of IgDCD27 DN B cells with 4-color
immunoﬂuorescence demonstrated this association (Fig. 2). Most,
but not all, of these cells were IgG-positive. All the IgG+ cells were
IgD, although not all the IgD cells were IgG+, suggesting that they
Fig. 1. Percentage (mean  SE) of the four B cell subpopulations according to the expression of IgD and CD27 in 34 young and 45 elderly. (a) p = NS; (b) p = NS; (c) p = 0.0001; and (d)
p = 0.005.
G. Colonna-Romano et al. /Mechanisms of Ageing and Development 130 (2009) 681–690 683switched the heavy chain of the immunoglobulin molecule,
probably in exchange for IgA.
3.3. ATP-binding-cassette-B1 transporter (ABCB1) expression in DN
(IgDCD27) B cells
We evaluated the ABCB1 levels in the four B cell populations
identiﬁed on the basis of IgD and CD27 expression. ABCB1 is a
member of the transmembrane protein family responsible for the
transport of various molecules across cell membranes (Efferth,
2003). These proteins are also extensively studied because they
mediate anti-drug resistance in cancer and are thought to be
involved in cytokine secretion (Efferth, 2003). As shown in box (a)
of Fig. 3, as previously demonstrated by Wirths and Lanzavecchia
(2005), CD27+ and CD27 B cells express different levels of ABCB1.
However, Fig. 3 shows that although it lacks CD27, the DN
population of B cells is ABCB1-negative, as is the case in classical
memory IgD CD27+ B cells. On the other hand, naı¨ve B cells
(IgD+CD27) and unswitched memory B cells (IgD+CD27+) are
ABCB1-positive (Fig. 3 shows a representative experiment).Fig. 2. Density plots of CD19+ cells stained with a combination of anti-IgD, anti-IgG, and a
cells and of IgG+CD27 B lymphocytes are marked in bold.Table 1 shows the mean ﬂuorescence intensity (MFI) values
obtained in a group of young and elderly donors (12 young and 8
elderly donors). Concerning the differences between cells obtained
from young or elderly subjects, we only observed a signiﬁcant
reduction in ABCB1 expression in unswitched B cells from elderly
donors. Incidentally, the reduced presence of ABCB1 in unswitched
memory B cells of elderly donors, compared to the same
population of young controls, suggests a different age-related
ability in the secretion of cytokines and other molecules (Efferth,
2003) from this subpopulation. However, the amount of ABCB1
was signiﬁcantly reduced in DN cells from both young and elderly
donors compared to naı¨ve and unswitched cells.
3.4. Telomere length evaluation
To estimate the replicative senescence of DN (IgDCD27) B
cells, we evaluated the telomere length in these cells. As shown in a
representative experiment in Fig. 4, naı¨ve B cells have long
telomeres, whereas classic switched memory B cells (IgDCD27+)
and DN B cells have short telomeres, so they are able to go towardnti-CD27monoclonal antibodies. The percentages of double-negative IgDCD27 B
Fig. 3. Expression of ABCB1 in the four B cell subpopulations identiﬁed on the basis of the expression of IgD and CD27 (representative experiment). The performance of B cells
from a young donor is shown. Speciﬁcally, IgDCD27DNB cells express low levels of ABCB1 as IgDCD27+memory B cells. In box (a) the analysis of ABCB1 on B cells gated on
the basis of the expression of CD27 (CD27+ and CD27) is shown. As described by others, CD27 B cells have higher levels of ABCB1 compared to CD27+ B cells.
Table 1
ABCB1 expression (as mean MFI SE) on the four B cell subpopulations studied in young and elderly subjects.
Naı¨ve (IgD+CD27) Unswitched (IgD+CD27+) Switched (IgDCD27+) DN (IgDCD27)
Young (n=12) 5.21.8 4.91.3 2.70.9 2.70.4
Elderly (n=8) 4.91.4 2.81.2 1.90.4 2.40.8
p* NS 0.015 NS NS
p§ 0.0009 <0.0001 NS
p# 0.01 NS NS
ANOVA test: *young vs. elderly analysis; §DN vs. the other three subpopulations in young donors; #DN vs. the other three subpopulations in elderly donors.
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Table 2 shows the MFI values indicative of telomere length in the
studied subjects (12 young and 8 elderly donors). Both in the young
and the elderly, memory DN cells have shorter telomeres
compared to memory unswitched and naı¨ve cells. Thus, no
differences were shown between naı¨ve and unswitched memory
B cells, whereas classic memory B cells and IgDCD27(DN) B cells
had a very similar telomere length. IgDCD27+ (switchedmemory)
and DN B cells of elderly donors had very short telomeres
compared to the same subpopulations of young donors.Table 2
Telomere length evaluated by ﬂow FISH assay. Values are expressed as the MFI (mean
Naı¨ve (IgD+CD27) Unswitched (IgD+
Young (n=12) 170.817.6 117.010.0




ANOVA test: *young vs. elderly analysis; §DN vs. the other three subpopulations in you3.5. Bcl2 expression
Individual Bcl2 family members couple the regulation of
apoptosis and cell cycle control in unique ways. In particular,
the anti-proliferativemolecule, Bcl2, is anti-apoptotic (Zinkel et al.,
2006). As described by Shi et al. (2003), CD27+ B lymphocytes show
higher levels of Bcl2 compared to CD27 B cells, and the ﬁndings in
Fig. 5a conﬁrm this. However, whenwe split the CD27 population
into naı¨ve IgD+CD27 and DN IgDCD27 cells, we observed that
DN cells had very low levels of Bcl2 compared to naı¨ve B cells SE) using a Cy5-conjugated PNA probe on B cell subpopulations.






ng donors; #DN vs. the other three subpopulations in elderly donors.
Fig. 4. Telomere length measurement by ﬂow ﬁsh in B lymphocyte subsets according to the expression of IgD and CD27 (representative experiment). The performance of B
cells obtained from a young donor is shown.
Table 3
CD80, HLA-DR, and CD40 expression (as the MFI mean SE) on CD27+ and CD27 B
lymphocytes (n =14;6 young and 8 elderly).
CD80 HLA-DR CD40
CD27+ 33.07.9 104.917.0 104.714.2
CD27 11.82.1 24.76.5 37.98.2
p 0.013 <0.0001 0.002
ANOVA test: CD27+ vs. CD27.
Fig. 5. (a) Bcl2 expression (mean of MFI values  SE) on CD27+ and CD27 B lymphocytes (p < 0.0001). (b) This last group of cells was split into IgD+CD27 (naı¨ve) and IgDCD27
(DN) B cells and Bcl2 expression was signiﬁcantly lower (p < 0.0022; n = 14.6 young and 8 elderly).
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as a single group, as no differences have been revealed between the
two age groups.
3.6. CD40, HLA-DR, and CD80 expression in DN B cells
It is well known that B cells act as good antigen presenting cells
(APC; Rodriguez-Pinto, 2005) and change the heavy chain of
secreted immunoglobulins after the interaction with T cells
through CD40-CD154 ligation (Rodriguez-Pinto and Moreno,
2005). We evaluated the four B cell populations studied for the
expression of HLA-DR and CD80 necessary to efﬁciently present
antigen and the CD40 necessary to activate isotype switching
(Rodriguez-Pinto, 2005; Rodriguez-Pinto and Moreno, 2005). In
Table 3, we show that there was a signiﬁcant reduction in CD80,
HLA-DR, and CD40 expression in CD27 B cells compared to CD27+
cells. In Fig. 6, we show that when CD27 B cells were split into
IgD+CD27 and IgDCD27 cells, CD80was expressed at negligible
levels in DN B cells, whereas naı¨ve B cells showed low, but
signiﬁcantly higher levels of CD80 when compared to the DNpopulation. A similar insigniﬁcant trend was observed in HLA-DR
and CD40 expression. Since no differences have been revealed
between the two age groups (data not shown), the data obtained in
young and old donors were analyzed as a single group.
3.7. Ki67 expression
B lymphocytes express Toll Like receptor 9 (TLR9) that bind
microbial DNA containing CpGmotifs, and activation of human and
murine B cells by CpG is well documented (Bekeredjian-Ding et al.,
Fig. 6. CD27 B lymphocytes were split into IgD+CD27 (naı¨ve) and IgDCD27 (DN) B cells and the CD80 (a), HLA-DR (b), and CD40 (c) expression (mean of MFI values  SE)
evaluated. CD80 (p = 0.006), HLA-DR (p = NS), CD40 (p = NS; n = 14.6 young and 8 elderly.
Table 4
Intracytoplasmatic expression of Ki67 in B cell subpopulations cultured in RPMI or CpG in young (a) and elderly (b) subjects. Values are expressed asmean ofMFI values SD.
(a)
Young (n=5)
Total B cells Naı¨ve (IgD+CD27) Unswitched (IgD+CD27+) Switched (IgDCD27+) DN (IgDCD27)
RPMI 14.07.4 36.012.5 74.056.2 18.611.9 18.411.8
CpG 118.464.1 210.082.5 251.5181.7 20.310.8 25.118.4
p 0.02a 0.03a 0.05a 0.2 0.2
(b)
Elderly (n=4)
Total B cells Naı¨ve (IgD+CD27) Unswitched (IgD+CD27+) Switched (IgDCD27+) DN (IgDCD27)
RPMI 25.02.0 15.70.5 23.8 0.9 49.07.0 46.57.5
CpG 46.80.6 36.03.8 46.72.2 57.86.6 49.38.7
p 0.02a 0.01a 0.01a 0.06 0.06
ANOVA test.
a CpG vs. RPMI.
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cell subset to be activated we evaluated the Ki67 expression
following 5 days of culture with CpG in PBMCs from young and
elderly donors. As shown in Table 4, total B cells from young
subjects are well stimulated by CpG whereas cells from elderly
donors show a reduced ratio of activation (8.45 vs. 1.87). The
analysis of Ki67 expression on the four B cell subsets show a
remarkable Ki67 expression in naı¨ve and memory unswitched B
cells of the young donors. A signiﬁcant response is also observed in
the same population of elderly patients, although at a reduced
ratio. Memory switched and DN cells of both young and elderly
donors do not show a signiﬁcant proliferation. In order to validate
the result obtained in DN cells, in Fig. 7 we evaluated the Ki67
expression in gated IgG+CD27 (i.e. DN IgDCD27). This popula-
tion does not show any staining problem.
In some young and elderly donors, we have also evaluated the
Ki67 expression after 5 days of culture with F(ab0)2, a polyclonal
mitogen of B cells that binds the B cell receptor (anti-BCR). In Fig. 8we show a typical experiment to evaluate the Ki67 expression, as
MFI, after stimulation of total B cells and their subsets through
their BCR. Ki67 expression was enhanced in total B cells and in all
the B subsets.
3.8. BrdU incorporation
The immunoﬂuorescent staining of incorporated BrdU with
ﬂow cytometric analysis provides a high resolution technique to
determine the frequency and nature of individual cells that have
synthesized DNA. In this method, BrdU is incorporated into newly
synthesized DNA by cells entering and progressing through the
DNA synthesis phase of the cell cycle (Gratzner and Leif, 1981). To
assess the ability of the different B cell subset to be activated, we
have also evaluated the BrdU incorporation by the proliferating
cells following 5 days of culture with CpG or F(ab0)2 in PBMCs from
young and elderly donors. As shown in a typical experiment in
Fig. 9, in DN (IgDCD27) B lymphocytes, after stimulation with
Fig. 7. Ki67 expressionwas evaluated in PBMC culturedwith CpG. The ﬁgure shows the expression of Ki67 in gated DN (IgDCD27 B cells) and IgG+CD27 B cells. PBMCwere
stained with anti-IgDPE or anti IgGPE,anti-CD19PECy5, anti-CD27APC and anti-Ki67FITC.
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unstimulated cells or after activation with CpG.
4. Discussion
Immunologicalmemory is a characteristic feature of instructive
immune responses. Immunological memory allows the immediate
response by pre-induced circulating antibodies and confers the
ability to mount a rapid and vigorous immune response after
repeated exposure to the same antigen by memory lymphocytes
(Lanzavecchia and Sallusto, 2005; Lanzavecchia et al., 2006). On
the other hand, it has been demonstrated that the frequency and
diversity of immune stimulation throughout life causes an increase
in the number of memory T cells. This circumstance is repeated in
long-lived subjects, rendering the elderly less able to respond to
new antigens (Pawelec et al., 2002b; Pawelec et al., 2005; Akbar
and Fletcher, 2005). In this regard, it has been proposed that the
immunological space in elderly people is ﬁlled by memory T cells
(Franceschi et al., 1995; Cossarizza et al., 1996; Franceschi et al.,
2000; Globerson and Effros, 2000). Furthermore, it has been
suggested that chronic antigenic stimuli, as occur with herpes
viruses, play a relevant role in exhausting the immune system
(Pawelec et al., 2002b; Ouyang et al., 2004; Akbar and Fletcher,
2005; Wikby et al., 2005; Colonna-Romano et al., 2007), due to the
clonal expansion of CD8 T cells and the consequent shrinkage of
the T cell repertoire (Pawelec et al., 2004, 2005). This state of affairs
has consequences, since elderly people show an increasedincidence of infections and an inadequate vaccine response (Hainz
et al., 2005; Kaml et al., 2006).
As changes in the B cell repertoire have also been described
both in mice and in humans (Weksler, 2000; Szabo et al., 2003,
2004), in this paper we have focused our attention on B memory
lymphocytes in the elderly. These cells have been deﬁned by the
expression of the membrane marker, CD27, which is involved in
the differentiation of B cells into antibody-secreting plasma cells
(Kobata et al., 1995; Agematsu et al., 2000). CD27+ B lymphocytes
have been assumed to be memory B cells because it has been
observed that they contain somatic Ig gene mutations (Klein et al.,
1998), and have switched the Ig class (Agematsu et al., 2000).
Finally, it has been reported that the percentage of CD27+ B
lymphocytes increase with age from cord blood to adults
(Agematsu et al., 2000) and to a lesser extent, in the elderly
(Colonna-Romano et al., 2003). Several years ago Shi et al. (2003)
demonstrated that circulating B cells can be divided (on the basis of
the expression of IgD and CD27) into three different functional
subsets: (1) IgD+CD27 naı¨ve B cells, (2) IgD+CD27+ memory
unswitched cells, and (3) IgDCD27+ classic memory switched
(IgG+ or IgA+) cells. Some of the unswitched cells also express IgM
and have been designated IgM memory B cells (IgD+IgM+CD27+),
while some of the IgDCD27+ (memory switched) are IgM+ and
have been designated IgM-only memory B cells (Shi et al., 2005). It
has been proposed that IgM memory B cells are involved in the
response to pneumococcal antigens and Shi et al. (2005) have
demonstrated that these cells are reduced in the elderly. This
Fig. 8. Ki67 expression on B cells and their subsets after stimulation with anti-BCR F(ab0)2.
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to bacterial infections.
Studying B cell populations in the elderly, our attention has
been drawn to B lymphocytes negative for both IgD and CD27.
These cells are signiﬁcantly higher in the elderly (Colonna-Romano
et al., 2008), together with a signiﬁcant reduction of naı¨ve B cells
described also by Gupta et al. (2005). The latter ﬁnding is not in
agreement with the data reported by Shi (Shi et al., 2005), as they
showed an increase of naı¨ve B cells in the elderly. This was an
unexpected result as it is assumed that elderly people have a highly
experienced immune system and a reduced output of B cells
(Globerson and Effros, 2000). In contrast, another paper (Frasca
et al., 2008) reports a reduced amount (percentage and absolute
number) of memory B cells in the aged, and an increased
percentage (but a reduced absolute number) of naı¨ve B cells in
the elderly. One possible explanation for these differences might
be the age of the subject studied (our elderly subjects were mean
age 89.0, median 91 years) whereas in Frasca’s paper the subjects
were about age 70 years. This could be a critical factor although
this is not the only difference between Frasca’s data and ours. The
results obtained from young donors are also different. On the other
hand our data obtained from young donors are consistent with
data reported by Sanz et al., 2008. Moreover, the amount of IgG
found in the serumby us (Listı` et al., 2006), and others (Frasca et al.,
2008; Franceschi et al., 1995) ﬁts well with the expansion of IgG+ B
cells.
However, the important results obtained fromourwork are that
an expanded population of DN B cells, expressing IgG but lacking
CD27 (IgDIgG+CD27) exists in the elderly. This kind of memory B
cell has also been described by Fecteau et al. (2006) in healthy
donors,Wei et al. (2007) in active Lupus patients, and by Sanz et al.
(2008) in healthy subjects challenged with respiratory syncizialvirus (RSV). The latter author hypothesizes that these cells might
participate in the early phases of protective memory responses.
To characterize DN B cells in our studied subjects, we have
evaluated the expression of the ATP-binding cassette and the
ABCB1 transporter, as Wirths and Lanzavecchia (2005) have
demonstrated that it is exclusively present in naı¨ve B cells and
absent inmemory B lymphocytes. From our data, we conclude that
this very small population of B cells behaves as CD27+ memory
lymphocytes because the IgD/CD27 DN population of B cells is
ABCB1-negative, whereas naı¨ve B cells (IgD+CD27) are ABCB1-
positive. Moreover unswitched memory B cells from elderly
donors seem to quickly acquire the memory phenotype as they
lose ABCB1 expression.
To evaluate the age of the DN B cells, we assessed the telomere
length of the four B cell populations studied. In fact, telomere
length is believed to be a goodmarker to study cellular senescence,
as well as ageing and the life expectancy of an organism (Cawthon
et al., 2003). Telomere length regulates the replicative capacity of
vertebrate somatic cells and reﬂects both the residual replicative
capacity and the history of one cell (Allsopp et al., 1992).
Our results show that DN cells expanded in the elderly have a
reduced replicative ability as also shown by the Ki67 expression
after in vitro culture with Cpg but not with F(ab0)2. Further, we
observed that DN cells have a very low level of Bcl2 when
compared to naı¨ve IgDCD27+CD27B cells. This is an unexpected
result as the presence of Bcl2 should preserve the cells from
apoptosis and should be responsible for the survival of these cells.
In fact these cells survive in vivo and in vitro (data not shown) and
are able to enter in cycle as shown by a higher incorporation of
BrdU in stimulated cultures compared to the unstimulated ones.
Notably switched memory and DN B cells from elderly subjects in
vitro show an ‘‘intrinsic’’ higher expression of Ki67 when cultured
Fig. 9. BrdU incorporation on double-negative B cells after stimulation with CpG (a)
or anti-BCR F(ab0)2.
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limited to certain stimulators, as observed for senescent CD28-CD8
T cells (Weng et al., 2009). To gain insight into the mechanisms of
this partially defective activation, further studies are needed,
including cytokine production evaluation.
Regarding the role of these cells, we conclude that it is a typical
phenomenon due to the ageing of the immune system;we consider
these cells exhausted memory cells that have reverted their
expression of CD27 as they have switched the heavy chain of
immunoglobulin, have low levels of ABCB1, and have short
telomeres. Finally, they have low levels of Bcl-2 and are therefore
likely prone to apoptosis.
What is the biological signiﬁcance of these cells? Are they
exhausted and just ﬁll the B cell immunological space, or might
they have another function, such as functioning as an APC? To try
to answer these questions, we evaluated the expression of HLA-DR
and CD80 necessary to efﬁciently present antigen to T cells
(Rodriguez-Pinto, 2005). Moreover, as CD40-CD154 binding is
necessary to activate isotype switching (Rodriguez-Pinto and
Moreno, 2005), we studied the expression of CD40 on CD27+ and
CD27 B cells. Our negative results suggest that these cells do not
express any of thesemarkers useful for antigen presentation and T-B cooperation. Moreover, the observation that these expanded DN
B cells are CD40-negative suggests that these cells might develop
outside the germinal center, as this circumstance has been
demonstrated in lupus-prone mice (William et al., 2002). In the
elderly, immunoglobulin production might elude T cell control.
This might explain the normal levels of Ig in the serum of old
donors (Listı` et al., 2006).
Our results strengthen the recent data of Wei et al. (2007)
obtained in lupus patients, suggesting that these DN cells are
memory B cells. The authors have debated the origin and
biological meaning of DN B cells and hypothesized that these
cells might be a distinct lineage of memory B cells or a progenitor
of memory CD27+ cells. We instead hypothesize that these cells
are senescent memory B cells that have down-modulated
(reverted) their expression of CD27 (Appay et al., 2002) like
speciﬁc CD8 T cells against chronic antigenic stimuli (e.g. herpetic
viruses; Pawelec et al., 2004, 2005). The exhaustion of the immune
system in the elderly has been demonstrated in the T cell branch
(Akbar and Fletcher, 2005), andwebelieve that this is also the case
in the B cell compartment. On the other hand, it has been
demonstrated that the time-enduring stimulation of the immune
system, as in patients with lupus (Anolik et al., 2004), is related to
the expansion of these cells and that the amount of DN B cells
correlates positively with the clinical manifestations of lupus
(Wei et al., 2007) Recent observations suggest thatmemory B cells
are highly heterogeneous (Wirths and Lanzavecchia, 2005;
Ehrhardt et al., 2005; Fecteau et al., 2006; Wei et al., 2007; Sanz
et al., 2008); they might play different roles in pathologic chronic
stimulation (e.g., lupus), and in chronic stimulation (e.g., the
elderly). Finally, we believe that knowledge of B-cell behaviour in
elderly people is a major issue in the immunesenescence ﬁeld
since B cells contribute to autoimmune disease, and B-cell tumors
constitute the greater part of hematological cancers in the elderly
(Chiorazzi et al., 2005), and B cells are also strongly related to the
vaccine response.
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